![Siobhan Fogarty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: - $ am 30.06.2026
Siobhan Fogarty is Chief Technical Officer at Tonix Pharmaceuticals Holding Corp.
since 2025.
Formerly, Ms. Fogarty was Vice President-Product Development at Tonix Pharma Ltd. from 2019 to 2021.
Education includes undergraduate studies at the University of Limerick and graduate studies at Trinity College Dublin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.03.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Technik-/Wissenschafts-/F&E-Leiter | 04.02.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Tonix Pharma Ltd.
 Tonix Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Trinity College Dublin
 Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Limerick
 University of Limerick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonix Pharmaceuticals Holding Corp.
 Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Tonix Pharma Ltd.
Tonix Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
